Valuation: Haemonetics Corporation

Market Cap 3.55B 3.11B 2.88B 2.65B 4.99B 342B 5.07B 34.36B 13.45B 167B 13.31B 13.03B 578B P/E 2027 *
19.8x
P/E 2028 * 17.6x
Enterprise Value 4.22B 3.7B 3.43B 3.15B 5.94B 407B 6.03B 40.88B 16B 199B 15.84B 15.49B 688B EV / Sales 2027 *
3.01x
EV / Sales 2028 * 2.67x
Free-Float
98.78%
Yield 2027 *
2.56%
Yield 2028 * -
1 day-0.05%
1 week+1.76%
Current month+4.04%
1 month+7.58%
3 months+27.65%
6 months+11.44%
Current year-2.65%
1 week 76.22
Extreme 76.22
79.57
1 month 71.81
Extreme 71.81
80
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.17
Extreme 29.17
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
5/6/26 Tax

VP, Chief Accounting Officer

-259 0.0006%
5/6/26 Tax

Head of Human Resources

-313 0.0007%
15/5/26 Tax

VP, Chief Accounting Officer

-2,417 0.0052%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+1.76%+5.15%-15.59% 3.55B
+0.90%+12.66%-20.01%-12.00% 175B
-0.56%+1.76%-10.65%-7.95% 105B
-0.82%+1.35%+2.60%+56.07% 58.48B
-0.82%-0.84%+33.62%+56.52% 51.36B
-0.44%-1.11%-15.51%-42.17% 42.2B
-4.89%-5.73% - - 31.44B
-4.44%-1.79%-16.08%-45.31% 27.56B
-0.23%-0.16%+63.73%-5.01% 25.32B
-0.56%-0.42%-5.87%-9.27% 20.52B
Average -0.99%+0.72%+4.11%-2.75% 54.04B
Weighted average by Cap. -0.17%+3.96%-4.58%-0.30%

Financials

2027 *2028 *
Net sales 1.4B 1.23B 1.14B 1.05B 1.97B 135B 2B 13.58B 5.32B 66.19B 5.26B 5.15B 229B 1.47B 1.29B 1.2B 1.1B 2.08B 142B 2.11B 14.29B 5.59B 69.61B 5.53B 5.41B 240B
Net income 176M 155M 143M 132M 248M 17.02B 252M 1.71B 669M 8.33B 662M 648M 28.77B 204M 179M 166M 152M 287M 19.67B 291M 1.98B 773M 9.62B 765M 749M 33.24B
Net Debt 672M 589M 547M 503M 947M 64.89B 961M 6.52B 2.55B 31.75B 2.52B 2.47B 110B 385M 337M 313M 288M 542M 37.13B 550M 3.73B 1.46B 18.17B 1.44B 1.41B 62.77B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
22/07/26 US$78.03 -0.05% 363,405
21/07/26 US$78.07 -0.13% 371,758
20/07/26 US$78.17 +0.40% 577,723
17/07/26 US$77.86 -0.82% 493,006
16/07/26 US$78.50 +2.37% 952,048
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
78.03USD
Average target price
86.60USD
Spread / Average Target
+10.98%

Quarterly revenue - Rate of surprise